SAN DIEGO, CA--(Marketwire - October 08, 2008) - Lpath, Inc. (OTCBB: LPTN) announced it has published two papers showing the role of sphingosine-1-phosphate (S1P) in ocular disorders. Dr. Maria Grant's laboratory at the University of Florida collaborated with Lpath on both papers.
